Concentra operates approximately 520 occupational health centers across 40+ states, providing workplace injury care, physical therapy, employer services, and drug/alcohol testing to corporate clients. The company serves as an outsourced medical provider for workers' compensation cases and pre-employment screening, generating recurring revenue through employer contracts. Concentra competes in the fragmented occupational health market with scale advantages in multi-state employer relationships.
Business Overview
Concentra generates revenue through fee-for-service contracts with employers and third-party administrators managing workers' compensation programs. The company benefits from high fixed-cost leverage across its center network, with incremental patient visits driving strong margins once centers reach breakeven utilization (typically 15-20 visits per day). Pricing power derives from multi-year employer contracts, regulatory compliance requirements (OSHA, DOT physicals), and switching costs for established corporate relationships. The 96.5% operating margin (likely reflecting EBITDA-based calculation) indicates significant depreciation/amortization from leveraged buyout structure.
Same-center visit volume growth driven by employment levels and workplace injury rates
New center openings and de novo ramp timelines (typically 18-24 months to maturity)
Employer contract wins/losses, particularly large national accounts (Fortune 500 clients)
Workers' compensation insurance pricing trends and state regulatory changes affecting reimbursement
Drug testing volume tied to employment screening activity and regulatory mandates
Risk Factors
Telemedicine adoption for minor workplace injuries could reduce center visit volumes, though hands-on physical therapy and DOT physicals remain in-person requirements
State-level workers' compensation reforms capping reimbursement rates or expanding employer self-insurance options that bypass third-party networks
Declining workplace injury rates due to automation and improved safety protocols reducing core demand drivers
Hospital systems expanding occupational health offerings with broader service integration and brand recognition
Regional competitors undercutting pricing in key markets, particularly for commodity services like drug testing
Large employers building in-house occupational health capabilities to reduce outsourcing costs
Elevated leverage at 5.55x Debt/Equity creates refinancing risk if EBITDA growth stalls or credit markets tighten significantly
Minimal reported capex ($0M TTM) may indicate deferred maintenance or slower growth investment, potentially impacting competitive positioning
High ROE (51.2%) driven by financial leverage rather than operational efficiency, amplifying downside risk in stress scenarios
Macro Sensitivity
moderate - Revenue correlates with employment levels and workplace activity, as more workers and higher industrial production drive injury volumes and pre-employment screening. However, workers' compensation is non-discretionary once injuries occur, providing downside protection. Economic expansions increase new center ROI through faster ramp times, while recessions pressure same-center volumes by 5-10% but rarely cause sustained declines.
Rising rates negatively impact valuation multiples for leveraged healthcare services companies and increase debt service costs on the $16.7B debt load (implied by 5.55 D/E ratio). However, the business generates strong cash flow ($300M operating cash flow on $2.2B revenue) to service debt. Rate increases of 100bps add approximately $15-20M in annual interest expense, manageable given current profitability but reducing financial flexibility.
Moderate exposure to credit conditions through two channels: (1) employer bankruptcies can disrupt contract revenue, though diversification across 15,000+ employer clients mitigates concentration risk, and (2) workers' compensation insurers' financial health affects payment timing and reimbursement rates. Tightening credit conditions may delay new center expansion if refinancing becomes challenging given high leverage.
Profile
value - The 9.2% FCF yield, 1.4x P/S ratio, and 6.0x EV/EBITDA suggest value orientation despite recent 23% three-month rally. High leverage and private equity ownership history (typical for occupational health roll-ups) attract distressed/special situations investors. Growth investors may be drawn to 13.9% revenue growth, but 51.2% ROE driven by leverage limits appeal to quality-focused funds.
moderate - Healthcare services stocks typically exhibit lower beta than broader market (0.7-0.9 range), but high financial leverage and concentrated business model increase idiosyncratic risk. Recent performance shows 23% three-month gain followed by modest longer-term returns, suggesting event-driven volatility around refinancing or operational inflection points.